» Articles » PMID: 38804500

Long-term Demyelination and Aging-associated Changes in Mice Corpus Callosum; Evidence for the Role of Accelerated Aging in Remyelination Failure in a Mouse Model of Multiple Sclerosis

Overview
Journal Aging Cell
Specialties Cell Biology
Geriatrics
Date 2024 May 28
PMID 38804500
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disorder affecting the central nervous system. Evidence suggests that age-related neurodegeneration contributes to disability progression during the chronic stages of MS. Aging is characterized by decreased regeneration potential and impaired myelin repair in the brain. It is hypothesized that accelerated cellular aging contributes to the functional decline associated with neurodegenerative diseases. We assessed the impact of aging on myelin content in the corpus callosum (CC) and compared aging with the long-term demyelination (LTD) consequents induced by 12 weeks of feeding with a cuprizone (CPZ) diet. Initially, evaluating myelin content in 2-, 6-, and 18-month-old mice revealed a reduction in myelin content, particularly at 18 months. Myelin thickness was decreased and the g-ratio increased in aged mice. Although a lower myelin content and higher g-ratio were observed in LTD model mice, compared to the normally aged mice, both aging and LTD exhibited relatively similar myelin ultrastructure. Our findings provide evidence that LTD exhibits the hallmarks of aging such as elevated expression of senescence-associated genes, mitochondrial dysfunction, and high level of oxidative stress as observed following normal aging. We also investigated the senescence-associated β-galactosidase activity in O4 late oligodendrocyte progenitor cells (OPCs). The senescent O4/β-galactosidase cells were elevated in the CPZ diet. Our data showed that the myelin degeneration in CC occurs throughout the lifespan, and LTD induced by CPZ accelerates the aging process which may explain the impairment of myelin repair in patients with progressive MS.

Citing Articles

Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis.

Maupin E, Adams K J Neurochem. 2025; 169(1):e16301.

PMID: 39831743 PMC: 11745082. DOI: 10.1111/jnc.16301.


Long-term demyelination and aging-associated changes in mice corpus callosum; evidence for the role of accelerated aging in remyelination failure in a mouse model of multiple sclerosis.

Parandavar E, Shafizadeh M, Ahmadian S, Javan M Aging Cell. 2024; 23(9):e14211.

PMID: 38804500 PMC: 11488340. DOI: 10.1111/acel.14211.

References
1.
Trifunovic A, Larsson N . Mitochondrial dysfunction as a cause of ageing. J Intern Med. 2008; 263(2):167-78. DOI: 10.1111/j.1365-2796.2007.01905.x. View

2.
von Bernhardi R, Eugenin-von Bernhardi L, Eugenin J . Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci. 2015; 7:124. PMC: 4507468. DOI: 10.3389/fnagi.2015.00124. View

3.
Wagner K, Cameron-Smith D, Wessner B, Franzke B . Biomarkers of Aging: From Function to Molecular Biology. Nutrients. 2016; 8(6). PMC: 4924179. DOI: 10.3390/nu8060338. View

4.
Ikeda M, Oka Y . The relationship between nerve conduction velocity and fiber morphology during peripheral nerve regeneration. Brain Behav. 2012; 2(4):382-90. PMC: 3432961. DOI: 10.1002/brb3.61. View

5.
Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H . Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo. JAMA Neurol. 2019; 76(12):1474-1483. PMC: 6692692. DOI: 10.1001/jamaneurol.2019.2399. View